Technical Development of a New Meningococcal Conjugate Vaccine

Background. Group A Neisseria meningitidis has been a major cause of bacterial meningitis in the sub-Saharan region of Africa in the meningitis belt. Neisseria meningitidis is an encapsulated pathogen, and antibodies against the capsular polysaccharide are protective. Polysaccharide–protein conjugat...

Descripción completa

Detalles Bibliográficos
Autores principales: Frasch, Carl E., Kapre, Subhash V., Lee, Che-Hung, Préaud, Jean-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639497/
https://www.ncbi.nlm.nih.gov/pubmed/26553667
http://dx.doi.org/10.1093/cid/civ595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639497/
https://www.ncbi.nlm.nih.gov/pubmed/26553667
http://dx.doi.org/10.1093/cid/civ595

Ejemplares similares